BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31383484)

  • 1. The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
    Tzeng TT; Lai CC; Weng TC; Cyue MH; Tsai SY; Tseng YF; Sung WC; Lee MS; Hu AY
    Vaccine; 2019 Nov; 37(47):7117-7122. PubMed ID: 31383484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells.
    Tzeng TT; Chen PL; Weng TC; Tsai SY; Lai CC; Chou HI; Chen PW; Lu CC; Liu MT; Sung WC; Lee MS; Hu AY
    J Biomed Sci; 2020 Apr; 27(1):47. PubMed ID: 32241276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and Immunogenicity of Influenza H7N9 Vaccine Antigens Produced Using a Serum-Free Suspension MDCK Cell-Based Platform.
    Chia MY; Lin CY; Chen PL; Lai CC; Weng TC; Sung WC; Hu AY; Lee MS
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines.
    Schmeisser F; Jing X; Joshi M; Vasudevan A; Soto J; Li X; Choudhary A; Baichoo N; Resnick J; Ye Z; McCormick W; Weir JP
    Influenza Other Respir Viruses; 2016 Mar; 10(2):134-40. PubMed ID: 26616263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.
    Liu L; Lu J; Li Z; Zhou J; Guo J; Li X; Liu J; Shu Y; Wang D
    Hum Vaccin Immunother; 2018 Mar; 14(3):532-539. PubMed ID: 29300686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of MDCK cell-derived influenza H7N9 vaccine candidates in ferrets.
    Chia MY; Hu AY; Tseng YF; Weng TC; Lai CC; Lin JY; Chen PL; Wang YF; Chao SR; Chang JY; Hwang YS; Yeh CT; Yu CP; Chen YC; Su IJ; Lee MS
    PLoS One; 2015; 10(3):e0120793. PubMed ID: 25799397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial.
    Wu UI; Hsieh SM; Lee WS; Wang NC; Kung HC; Ou TY; Chen FL; Lin TY; Chen YC; Chang SC
    Vaccine; 2017 Jul; 35(33):4099-4104. PubMed ID: 28668573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development.
    Chen TH; Liu WC; Chen IC; Liu CC; Huang MH; Jan JT; Wu SC
    Vaccine; 2019 Nov; 37(47):6933-6941. PubMed ID: 31383491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
    Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Stable Influenza Virus Hemagglutinin through Structure-Guided Recombination.
    Tsai CH; Wei SC; Jan JT; Liao LL; Chang CJ; Chao YC
    ACS Synth Biol; 2019 Nov; 8(11):2472-2482. PubMed ID: 31565926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin.
    Ning T; Nie J; Huang W; Li C; Li X; Liu Q; Zhao H; Wang Y
    J Infect Dis; 2019 Jan; 219(1):19-25. PubMed ID: 29982588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primates.
    Pan W; Han L; Dong Z; Niu X; Li Z; Bao L; Li C; Luo Q; Yang Z; Li X; Huang J; Feng L; Qin C; Zhong N; Chen L
    Antiviral Res; 2014 Jul; 107():1-5. PubMed ID: 24746458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.
    Krammer F; Jul-Larsen A; Margine I; Hirsh A; Sjursen H; Zambon M; Cox RJ
    Clin Vaccine Immunol; 2014 Aug; 21(8):1153-63. PubMed ID: 24943383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in Interferon-Stimulated Genes Contributes to High-Yield Production of Influenza Virus in Suspension MDCK Cells.
    Wang Q; Luo J; Li B; Ye Q; Xu W; Gao F; Zhou L; Lu W; Tan WS; Li X
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.
    Khurana S; Coyle EM; Verma S; King LR; Manischewitz J; Crevar CJ; Carter DM; Ross TM; Golding H
    Vaccine; 2014 Nov; 32(48):6421-32. PubMed ID: 25284811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.